Breast Cancer Research

official impact factor 5.79

Highly Access

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists

Hetty Carraway* and Manuel Hidalgo

Breast Cancer Res 2004, 6:219-224 doi:10.1186/bcr927

Accesses  

  • Last 30 days: 114 accesses
  • Last 365 days: 1087 accesses
  • All time: 10184 accesses